Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stromal Cells for Biologic Refractory Crohn's Disease
NCT01090817Phase 2Completed
- Sponsor
- R.P. Herrmann
- Start
- Jan 2010
- Primary completion
- Jun 2014
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Provacel in Crohn's disease, sponsored by R.P. Herrmann. Primary endpoint: Clinical response to MSC at 6 weeks. Started Jan 2010; status: completed.
02
Drugs
Provacel
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01090817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090817.